Search

State

Industry

Company

HOSPITAL & MEDICAL SERVICE PLANS

Redevelopment Agreement

Centene Corp

REDEVELOPMENT AGREEMENT Redevelopment Agreement REDEVELOPMENT AGREEMENT FOR THE FORSYTH/HANLEY REDEVELOPMENT AREA BETWEEN THE CITY OF CLAYTON, MISSOURI AND CENTENE PLAZA REDEVELOPMENT CORPORATION Dated: December 30, 2005 TABLE OF CONTENTS Page Recitals 1 ARTICLE 1 INCORPORATED ITEMS; DEFINITIONS; EXHIBITS 1.01 Items Incorporated into this Agreement; Coordination with Redevelopment Plan 2 1.02 Defi

SEMICONDUCTORS & RELATED DEVICES

"S" Process Development Agreement

Advanced Micro Devices Inc

"S" PROCESS DEVELOPMENT AGREEMENT "S" Process Development Agreement *** Confidential treatment has been requested as to certain portions of this agreement. Such omitted confidential information has been designated by an asterisk and has been filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and the Commission’

PHARMACEUTICAL PREPARATIONS

IO DISCOVERY AND DEVELOPMENT AGREEMENT BY

Regeneron Pharmaceuticals, Inc.

IO DISCOVERY AND DEVELOPMENT AGREEMENT BY AND BETWEEN THE REGISTRANT AND SANOFI Document IMMUNO-ONCOLOGY DISCOVERY AND DEVELOPMENT AGREEMENT By and Between SANOFI BIOTECHNOLOGY SAS and REGENERON PHARMACEUTICALS, INC. Dated as of July 1, 2015 CERTAIN PORTIONS OF THIS HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIALITY. SUCH OMITTED PORTIONS, WHICH ARE MARKED WITH BRACKETS AND THREE ASTERISK

RETAIL-EATING & DRINKING PLACES

1 DEVELOPMENT AGREEMENT ADDENDUM REGARDING

Starbucks Corp

.1 1 DEVELOPMENT AGREEMENT ADDENDUM REGARDING SPECIALTY SANDWICH PROGRAM THIS DEVELOPMENT AGREEMENT ADDENDUM (THE "ADDENDUM") is entered into effective as of the 3rd day of January, 1998 (the "Sandwich Program Effective Date"), by and between Starbucks Corporation ("Starbucks") and Host International, Inc. ("Licensee"). RECITALS: WHEREAS, Starbucks and Licensee are parties to that certain develop

PHARMACEUTICAL PREPARATIONS

CONFIDENTIAL TREATMENT FIRST

Vertex Pharmaceuticals Inc / Ma

CONFIDENTIAL TREATMENT FIRST REVISED AND RESTATED RESEARCH AND EARLY DEVELOPMENT AGREEMENT BETWEEN VERTEX PHARMACEUTICALS INCORPORATED AND NOVARTIS PHARMA AG [Certain redacted non-public information has been filed separately with the Securities and Exchange Commission.] RESEARCH AND EARLY DEVELOPMENT AGREEMENT TABLE OF CONTENTS Page Number INTRODUCTION1 ARTICLE I - DEFINITIONS1 ARTICLE II RESEARC

CRUDE PETROLEUM & NATURAL GAS

Development Agreement

True North Energy Corp

DEVELOPMENT AGREEMENT THIS DEVELOPMENT AGREEMENT (“Agreement”), made and entered into effective as of October 1, 2006 (the “Effective Date”), by and between BP AMERICA PRODUCTION COMPANY (“BP”), a Delaware corporation, with an office at 501 Westlake Park Boulevard, Houston, Texas 77079, and TRUE NORTH ENERGY CORP. (“Company”), a Nevada corporation, with an office at 1200 Smith Street, 16th Floor,

PHARMACEUTICAL PREPARATIONS

Development Agreement

Acadia Pharmaceuticals Inc

DEVELOPMENT AGREEMENT Development Agreement Certain confidential information contained in this document, marked by brackets and asterisks, has been omitted pursuant to a request for confidential treatment pursuant to 17 C.F.R. Sections 200.80(b)(4), 200.83 and 230.406, and has been filed separately with the Securities and Exchange Commission DEVELOPMENT AGREEMENT THIS DEVELOPMENT AGREEMENT (this “

PHARMACEUTICAL PREPARATIONS

Development Agreement

Acura Pharmaceuticals, Inc

LICENSE AND DEVELOPMENT AGREEMENT This License and Development Agreement (“Agreement”) is made and entered into as of this June 5, 2015 (the “Effective Date”) by and between Bayer HealthCare LLC, with offices at 100 Bayer Blvd., Whippany, NJ 07981 (“Bayer”), and Acura Pharmaceuticals, Inc., with offices at 616 N. North Court, Palatine IL 60067 (“Acura”). Bayer and Acura each are referred to herei

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

COOPERATIVE DEVELOPMENT AGREEMENT

Altus Pharmaceuticals Inc.

COOPERATIVE DEVELOPMENT AGREEMENT exv10w1 COOPERATIVE DEVELOPMENT AGREEMENT THIS AGREEMENT, entered into as of the 8th day of November, 2002, by and between ALTUS BIOLOGICS INC., a corporation organized and existing under the laws of the State of Delaware and having its principal place of business at 625 Putnam Avenue, Cambridge, MA 02139 (hereinafter called “ALTUS”), and AMANO ENZYME INC., a cor

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Development Agreement

Adynxx, Inc.

THE COMPANY HAS REQUESTED AN ORDER FROM THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, GRANTING CONFIDENTIAL TREATMENT TO SELECTED PORTIONS. ACCORDINGLY, THE CONFIDENTIAL PORTIONS HAVE BEEN OMITTED FROM THIS EXHIBIT, AND HAVE BEEN FILED SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS ARE INDICATED IN THIS WITH